SPOTLIGHT -
Comprehensive insight on the various healthcare team members a hematologist-oncologist may work with to optimize care of myeloproliferative neoplasms.
FDA Approves Ojjaara to Treat Myelofibrosis With Anemia
The FDA approved Ojjaara for intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythaemia vera and post-essential thrombocythaemia), in adults with anemia.
Read More
LeVar Burton Helping the MPN Community Through Advocacy and Storytelling
On this episode of the “Cancer Horizons” podcast, LeVar Burton sits down with CURE® to talk about the importance of MPN awareness and the power of storytelling in advocacy.
Listen
Patients with MPNs ‘Don’t Know What They Don’t Know'
Nurse practitioner Charina Toste explains why it is important for patients to be empowered to have educated conversation with their care teams.
Recognizing Advancements and the Individuals Who Made Them in Myeloproliferative Neoplasms
In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Laura Michaelis, a 2019 CURE MPN Hero, about how far we’ve come in the myeloproliferative neoplasm space.
A Look at This Year’s MPN Updates
We took a look back at the most noteworthy and compelling myeloprolifearative neoplasm stories from 2023.
'No Symptom is Too Small’ for Patients With MPNs
Patients with MPNs can potentially experience long asymptomatic periods, and it’s up to patients and providers to remain vigilant as they monitor and manage symptoms.